Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats

Physiological Research

Volumn 55, Issue 2, 2006, Pages 157-164

  Ulicna O ^a   Vancova O ^a   Bozek P ^b   Carsky J ^a   Sebekova K ^c   Boor, P ^c   Nakano, M ^d   Greksak M ^e,f  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b State Hospital   (Slovakia)

^c SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^d Nagoya University of Economics   (Japan)

^e INSTITUTE OF CHEMISTRY   (Slovakia)

^f Institute of Animal Biochemistry and Genetics   (Slovakia)

Author keywords

Aspalathus linearis; Oxidative stress; Rooibos tea; Streptozotocin induced diabetes

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ASPALATHUS LINEARIS EXTRACT; BIOCHEMICAL MARKER; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LIPID; MALONALDEHYDE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ASPALATHUS; BEVERAGE; CELL PROTECTION; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HYDROPHILICITY; HYDROPHOBICITY; LENS; LIPID PEROXIDATION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES; TEA;

ACETYLCYSTEINE; ANIMALS; ASPALATHUS; DIABETES MELLITUS, EXPERIMENTAL; HYDROGEN-ION CONCENTRATION; MALE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 33646147802     PISSN: 08628408     EISSN: 08628408     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ALTOMARE E, VENDEMAILE G, GRATTANGLIANO I, ANGELINI P, MICELLI-FERRARI T, CARDIA L: Human diabetic cataracts: role of lipid peroxidation. Diabetes Metab 21: 173-179, 1995.
2. BAYDAS G, CANATAN H, TURKOGLU A: Comparative analysis of the protective effects of melatonin and vitamin E on streptozotocin-induced diabetes melitus. J Pineal Res 32: 225-230, 2002.
3. BAYRAKTUTAN U: Free radicals, diabetes and endothelial dysfunction. Diabetes Obes Metab 4: 224-238, 2002.
4. BENZIE IFF, SZETO YT: Total antioxidant capacity of teas by the ferric reducing antioxidant power assay. J Agric Food Chem 47: 633-636, 1999.
5. BONNEFONT-ROUSSELOT D: Glucose and reactive oxygen species. Curr Opin Nutr Metab Care 5: 561-568, 2002.
6. BRAMATI L, MINOGGIO M, GARDANA C, SIMONETTI P, MAURI P, PIETTA P: Quantitative characterisation of flavonoid compounds in Rooibos tea (Aspalathus linearis) by LC-UV/DAD. J Agric Food Chem 50: 5513-5519, 2002.
7. BRAMATI L, AQUILANO F, PIETTA P: Unfermented rooibos tea: quantitative characterisation of flavonoids by HPLC-UV and determination of the total antioxidant activity. J Agric Food Chem 51: 7472-7474, 2003.
8. BUCALA R, CERAMI A: Advanced glycosylation: chemistry, biology and implications for diabetes and aging. Adv Pharmacol, 23: 1-34, 1992.
9. CARNOVALE CE, ROMA MG, MONTI JA, RODRIGUEZ GARAY EA: Studies on the mechanisms of bile-salt independent bile flow impairment in streptozotocin-induced hepatotoxicity. Toxicology 68: 207-215, 1991.
10. FLÜCKINGER R, WINTERHALTER KH: In vitro synthesis of hemoglobin AIC. FEBS Lett 71: 356-360, 1976.
11. FURST P: The role of antioxidants in nutritional support. Proc Nutr Soc 55: 945-961, 1996.
12. HESSELING PB, JOUBERT JR: The effect of rooibos tea on the type I allergic reaction. S Afr Med J 62: 1037-1038, 1982.
13. INANAMI O, ASANUMA T, INUKAI N, JIN T, SHIMOKAWA S, KASAI N, NAKANO M, SATO F, KUWABARA M: The suppression of age-related accumulation of lipid peroxides in rat brain by administration of Rooibos tea (Aspalathus linearis). Neurosci Lett 196: 85-88, 1995.
14. JOHNSON RN, METCALF PA, BAKER JR: Fructosamine a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127: 87-95, 1982.
15. KALOUSOVÁ M, ŠKRHA J, ZIMA T: Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51: 597-604, 2002.
16. 9 redox state and inhibition of oxidativer stress by rooibos tea (Aspalathus linearis) administration in carbon tetrachloride liver damage. Physiol Res 53: 515-521, 2004.
17. LAMPE JW: Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies. Am J Clin Nutr 70: 475S-490S, 1999.
18. MARNEWICK JL, JOUBERT E, VAN DER WESTHUIZEN F, GELDERBLOM WC: Modulation of hepatic drug metabolizing enzymes and oxidative status by rooibos tea (Aspalathus linearis) and Honeybush (Cyclopia intermedia), green and black (Camellia sinensis) teas in rats. J Agric Food Chem 51: 8113-8119, 2003.
19. MARTÍNEZ-CAYUELA M: Oxygen free radicals and human disease. Biochimie 77: 147-161, 1995.
20. MÜNCH G, KEIS R, WESSELS A, RIEDERER P, BAHNER Y, HEIDLAND A, NIWA T, LEMKE HD, SCHINZEL R: Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem 35: 669-677, 1997.
21. NAKANO M, ITOH Y, MIZUNO T, NAKASHIMA H: Anti-HIV activity of polysaccharides from rooibos tea and Japanese tea leaves. In: Proceedings of the International Symposium on Tea Culture and Health Science, Kakegawa (Japan), ISTeCH Press 1996, pp177-181.
22. NAKANO M, NAKASHIMA H, ITOH Y: Anti-human immunodeficiency virus activity of oligosaccharides from rooibos tea (Aspalathus linearis) extracts in vitro. Leukemia 11 (Suppl 3): 128-130, 1997a.
23. NAKANO M, ITOH Y, MIZUNO T, NAKASHIMA H: Polysaccharide from Aspalathus linearis with strong anti-HIV activity. Biosci Biotech Biochem 61: 267-271, 1997b.
24. PILZ J, MEINKE I, GLEITER CHH: Measurement of free and bound malondialdehyde in plasma by high performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatogr B 742: 315-325, 2000.
25. RABE CH, STEENKAMP JA, JOUBERT E, BURGER JFW, FERREIRA D: Phenolic metabolites from Rooibos tea (Aspalathus linearis). Phytochemistry 35: 1559-1565, 1994.
26. RUHE RC, MCDONALD RB: Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 20: 363S-369S, 2001.
27. SIES H: Strategies of antioxidant defence. Eur J Biochem 215: 213-219, 1993.
28. SHAPIRO K, GONG WC: Natural products used for diabetes. J Am Pharm Assoc 42: 217-226, 2002.
29. STRAFACE E, RIVABENE R, MASELLA R, SANTULLI M, PAGANELLI R, MALORNI W: Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: protective effects of N-acetylcysteine. Biochem Biophys Res Commun 290: 1393-1398, 2002.
30. SZKUDELSKI T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 537-546, 2001.
31. TREVISANATO SI, KIM Y: Tea and health. Nutrition Rev 58: 1-10, 2000.
32. 4 -induced liver damage in rats. Physiol Res 52: 461-466, 2003.
33. VURAL H, SABUNCU T, ARSLAN SO, AKSOY N: Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J Pineal Res 31: 193-198, 2001.
34. WEST IC: Radicals and oxidative stress in diabetes. Diabetic Med 17: 171-180, 2000.
35. WITKO-SARSAT V, FRIEDLANDER M, CAPEILLERE-BLANDIN C, NGUYEN-KHOA T, NGUYEN AT, ZINGRAFF J, JUNGERS P, DECAMPS-LATSCHA B: Advanced oxidation protein products as a new marker of oxidative stress in uremia. Kidney Int 49: 1304-1313, 1996.